A Letter of Safety Warning To CVS, Rite Aid And Their Pharmacists

The Potential Danger of Indiscriminate COVID-19 Vaccination In The Naturally Immune And Recently COVID-19 Infected.

Hooman Noorchashm
5 min readApr 29, 2021
CVS CEO, Karen S. Lynch (Left), and Rite Aid CEO, Heyward R. Donigan (Right).

Dear Ms. Donigan, Ms. Lynch and pharmacist colleagues,

I write this open letter of safety warning and concern to you as an immunologist and physician — so as to, both, help protect a subset of American patients I know to be at totally avoidable risk of harm, and to help provide you and your risk managers and attorneys with information to limit your corporations’ liability against what I believe is the high likelihood of impending litigation by customers harmed as such.

Specifically, I am writing to inform you that CVS and Rite Aid customers , who are either naturally immune to or recently infected by SARS-CoV-2, are likely to be at risk of harm when your pharmacists indiscriminately vaccinate them using the COVID-19 vaccines from Pfizer and Moderna.

I have extensively communicated my safety concerns about the indiscriminate COVID-19 vaccination of the already naturally immune and recently infected to the United States Food and Drug Administration, as well as to the executives at Pfizer and Moderna. These entities have chosen, so far, to ignore these safety concerns to the lives of a “minority subset” of Americans.

However, because CVS and Rite Aid, as private corporations, are now engaged in population level blanket vaccination, I am writing to inform you that the risk of liability for harm to persons who are naturally immune or recently infected, from indiscriminate COVID-19 vaccination, is focused on your corporation and pharmacist colleagues.

Let me be clear, on two main points of liability your attorneys may understand well:

  1. It is abundantly clear that the vast majority of persons who are naturally immune from prior SARS-CoV-2 infections gain little to no benefit from additional vaccination. This statement is not only consistent with the basic tents of immunological clinical science, but it was also demonstrated by the results from the J&J vaccine’s clinical trials AND by recent results emerging from Israel (see below links). Therefore, vaccination of the naturally immune is simply an unnecessary medical treatment in the vast majority of such persons. And you all know that any complications resulting from a medical treatment that is unnecessary, no matter how “rare”, fit under the category of “unreasonable harm”. Please do review THIS and THIS links with care and along with your risk managers and attorneys to consider the fact that many of the CVS and Rite Aide customers receiving indiscriminate vaccinations by your practitioners are undergoing an unnecessary, and therefore only potentially harmful, medical treatment within your facilities nationwide.
  2. As a matter of clinical standard we already know that vaccinating infected persons is potentially harmful. Certainly, recent CDC guideline indicates that persons infected with SARS-CoV-2 should wait for 3 months before getting vaccinated — this is an implicit acknowledgement that such persons are at risk of harm. Certainly, we already know that a substantial number of persons are asymptomtically infected with SARS-CoV-2 and, thus, will not know that they are infected at the time of their vaccination at your facilities. Moreover, recent data emerging from the UK is demonstrating that ambulatory patients with prior infections are the ones having the most intense vaccine related adverse reactions. You may review this data HERE. Of course, any reasonable epidemiologist, clinician or attorney would recognize that when the bell-shaped curve of adverse events is shifted to the right on the x-axis for the naturally infected, a lot more of the tail end of that bell-curve will be in “death valley”. In fact, there are some very prominent examples of death and complications from indiscriminate COVID-19 vaccination of the recently infected in the press. Names like Dr. J. Barton Williams of TN, Mr. Christopher Sarmiento of NM, and Ms. Brandy Parker-McFadden of TN. These persons with prior infections, who developed post-vaccine complications, are only 3 examples of Americans harmed, and will likely be the tip of a far larger iceberg. The shame is that most such individuals are highly likely to be naturally immune and, in truth, do not benefit from the vaccinations that trigger their complications or deaths — but even more shameful is that harm to these persons could be avoided if only our nation’s public health and corporate leaders were more circumspect and did NOT allow indiscriminate vaccination of the the recently infected and already immune.

I trust that you and your attorneys are able to process the information I’ve provided you objectively and understand that very simply mitigation approaches are possible to exclude those persons who are naturally immune, or recently infected, from a risk of harm within your vaccination facilities. These miitgation strategies MUST include: a) a proper history from the patient to exclude anyone with a known history of prior SARS-CoV-2 infection, and b) screening of vaccine candidates for anti-viral antibodies and viral antigen, before vaccination (i.e., #ScreenB4Vaccine).

To summarize, here, I am informing you of the potential risk of serious medical harm to at least a minority subset of your customers during this pandemic outbreak. Specifically, I am informing you that if indiscriminate COVID-19 vaccination in persons who are naturally immune or recently infected triggers serious illness or death, your awareness of this possibility now, poses a serious liability to your corporations — and especially IF you do not act to mitigate against this risk of harm to, at least some of your customers nationwide. I propose a #ScreenB4Vaccine approach AND a thorough “exposure and clinical intake history” prior to vaccination.

I’d be happy to discuss the potential risk I’ve informed you of here, in person if you wish.

In defense of US public health and the minority subsets of persons in potential harm’s way,

Hooman Noorchashm MD, PhD

noorchashm@gmail.com

--

--

Hooman Noorchashm
Hooman Noorchashm

Written by Hooman Noorchashm

Hooman Noorchashm MD, PhD is a physician-scientist. He is an advocate for ethics, patient safety and women’s health. He and his 6 children live in Pennsylvania.

Responses (2)